When I read the edig figure of "$20B in annual sales of infringing product" I believe they mean that is the sales of the infringing products NOT revenues to EDIG.

If we take a royalty of 1% (maybe less) that would be $200M per year in royalties to EDIG. That would convert to something much less in upfront one-time payments.

I think we are a screaming buy at this 10-12 cent level. Momentum alone on the next legal announcement could take us back to 20-25 range. Resistance is in the 25-30 cent range. We'll need multiple announcements of substance to get past that level........but even at that level you would be looking at 100+% gains.

biomedman